SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-023375
Filing Date
2021-05-04
Accepted
2021-05-04 16:28:31
Documents
60
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q oncr-10q_20210331.htm 10-Q 1300348
2 EX-31.1 oncr-ex311_6.htm EX-31.1 16252
3 EX-31.2 oncr-ex312_7.htm EX-31.2 16155
4 EX-32.1 oncr-ex321_8.htm EX-32.1 7643
5 EX-32.2 oncr-ex322_9.htm EX-32.2 7571
  Complete submission text file 0001564590-21-023375.txt   4645483

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oncr-20210331.xml EX-101.INS 853805
7 XBRL TAXONOMY EXTENSION SCHEMA oncr-20210331.xsd EX-101.SCH 38075
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oncr-20210331_cal.xml EX-101.CAL 37269
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oncr-20210331_def.xml EX-101.DEF 114555
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE oncr-20210331_lab.xml EX-101.LAB 312796
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oncr-20210331_pre.xml EX-101.PRE 246661
Mailing Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142
Business Address 450 KENDALL STREET 5TH FLOOR CAMBRIDGE MA 02142 617-425-9200
Oncorus, Inc. (Filer) CIK: 0001671818 (see all company filings)

IRS No.: 473779757 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39575 | Film No.: 21888944
SIC: 2834 Pharmaceutical Preparations